EYETECH PHARMACEUTICALS INC·4

Jul 1, 4:27 PM ET

EYETECH PHARMACEUTICALS INC 4

4 · EYETECH PHARMACEUTICALS INC · Filed Jul 1, 2005

Insider Transaction Report

Form 4
Period: 2005-07-01
SBLENDORIO GLENN
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2005-07-01$12.59/sh1,850$23,29243,095 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2005-07-011,85062,329 total
    Exercise: $1.36From: 2002-02-21Exp: 2012-02-21Common Stock (1,850 underlying)
  • Exercise/Conversion

    Common Stock

    2005-07-01$1.36/sh+1,850$2,51644,945 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2005-07-011,850117,771 total
    Exercise: $1.36From: 2002-02-21Exp: 2012-02-21Common Stock (1,850 underlying)
Footnotes (1)
  • [F1]Transaction effected pursuant to a 10b5-1 plan dated April 25, 2005.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT